Ginkgo Bioworks Holdings, Inc. (DNA) › Operating Cash FlowGinkgo Bioworks Holdings, Inc. (DNA) — Operating Cash FlowAnnual figures by fiscal year, from SEC filings.2019: -$44.66M2020: -$135.83M2021: -$253.82M2022: -$252.20M2023: -$295.50M2024: -$319.58M2025: -$171.06M-$171.06M2019Operating Cash Flow (USD)2025Fiscal YearOperating Cash FlowChange YoY2025-$171.06M+46.5%2024-$319.58M-8.2%2023-$295.50M-17.2%2022-$252.20M+0.6%2021-$253.82M-86.9%2020-$135.83M-204.1%2019-$44.66M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsCapital ExpendituresShares OutstandingDividends Per Share